Moreover, we discuss the observed plasma insulin clearance rates in the context of the observed plasma insulin concentrations to provide insight into the dose-dependent and independent effects of obesity and T2D on plasma insulin clearance. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.